A moment of lightheartedness, escape, and relief during the hospital treatment process. This is how technology meets medicine, thanks to the project " Virtual Reality to Support Cancer Patients ," promoted by the Associazione Salute Donna Odv – Sardinia section, in collaboration with AVAS, the Sardinian Offshore Sailing Shipowners' Sports Association, in the presence of the company's top management. The initiative will be presented on Monday, March 30, at 11:00 a.m., in the Ciccu Hall of the Presidio San Michele dell'Arnas G. Brotzu. The initiative was born thanks to donations raised during the fifth edition of Sail for Women , a charity sailing event that supported the purchase and development of innovative tools designed to improve the quality of life of patients during their treatment.

The virtual reality headsets will be distributed among the Hematology-Oncology department at Businco Hospital, the Pediatric Hematology-Oncology department at Microcitemico Hospital, the ASL 8 Hospice, and the Oncology department at Carbonia Hospital. Twelve immersive videos, shot in some of Sardinia's most evocative locations , have been uploaded to the headsets, with the aim of offering patients moments of escape and relief during treatment or hospital stays. The project was made possible thanks to the contribution of industry professionals: Roberto Lai, who designed the graphics, and Gianluca Demontis, head of video production.

The use of virtual reality in oncology is now an increasingly widespread non-pharmacological support strategy: numerous studies demonstrate how immersive experiences help reduce anxiety, stress, and pain perception, significantly improving patients' experience during complex treatments such as chemotherapy. Specifically, even short immersive sessions promote a reduction in discomfort through cognitive distraction mechanisms, help combat symptoms such as nausea and fatigue, and allow patients to temporarily "distance" themselves from the hospital environment, immersing themselves in natural and relaxing environments. The technology also stands out for its high tolerability, proving well accepted by over 85% of patients. This innovative approach aims not only to cure the disease but also to improve the quality of life during therapy.

(Unioneonline)

© Riproduzione riservata